© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Sparfloxacin stands out as a synthetic antibacterial compound from the fluoroquinolone class, distinguished by its powerful activity against a variety of bacteria. Its chemical formula, C19H22F2N4O3, anchors its identity and function. In the pharmaceutical landscape, sparfloxacin has played a big role in treating respiratory and urinary tract infections. Doctors and chemists recognize it for its reliable action against some Gram-positive and Gram-negative pathogens. With broad clinical study backings, the therapeutic properties of sparfloxacin have become clear, helping in hospitals and clinics to manage complicated bacterial infections.
Sparfloxacin often takes the form of pale yellowish to off-white crystalline powder. In the lab or factory, its physical manifestations show up as dense flakes and sometimes as solid pearls, depending on how it's processed. The solid state offers easy handling and measurable stability. Its crystals reflect its purity and manufacturing quality. Measured at around 1.5 g/cm³, the density places sparfloxacin in line with similar fluoroquinolones, making it easy to store or transport in bulk. Medical professionals and lab workers note its strong odorless presence, and its low solubility in water influences the method chosen for tablet or capsule formulations. For those working with raw materials, safe handling demands proper protective gear due to its dust and potential irritant qualities.
The molecule features a tricyclic core fused with two fluorine atoms, giving sparfloxacin its distinctive antibacterial edge. This structure generates strong binding with bacterial DNA gyrase and topoisomerase IV, which disables DNA replication in targeted pathogens. Molecular weight clocks in at approximately 392.4 g/mol, guiding precise formulation in pharmaceutical manufacturing and research settings. Chemists use this value to ensure accurate mixture calculations, especially when integrating sparfloxacin into complex drugs. The atomic layout, featuring carbon, hydrogen, fluorine, nitrogen, and oxygen, gives rise to the compound’s robust action and its safety margin in human therapies when used correctly.
Responsible manufacturers prioritize purity and consistency in sparfloxacin production. Raw materials undergo strict sourcing, and synthesis routes are optimized to ensure the lowest possible impurity profiles. Workers in the raw materials sector wear masks and gloves, and operate with effective ventilation to cut down exposure to fine powder during the weighing, transfer, and packing steps. Exporters and buyers track the product using the unique HS Code 29419019, ensuring smooth customs clearance and reliable traceability in international markets. With this code, logistic teams and healthcare distributors can verify compliance with import-export laws, and quality assurance teams confirm the chain of custody for every batch.
Sparfloxacin’s presence in any formulation comes with a set of safety instructions. Breathing in dust or extended contact with the solid or solution form can cause headaches, dizziness, and skin irritation, even if rare. Nitrile gloves, dust masks, and safety goggles form the frontline against accident or accidental contact. Chemical waste teams must neutralize and properly dispose of leftovers, respecting facility policy and national toxic substance protocols, to prevent environmental release or waterway contamination. Transport specialists check for leaks and package integrity before sending shipments. All stakeholders reference Safety Data Sheets (SDS) and train staff annually in hazard prevention, fostering a culture of responsibility throughout the handling lifecycle.
Quality managers evaluate every lot before it enters medicine production. Tests check for appearance, moisture content, identity, particle size distribution, and the unique melting point of about 250°C (with slight variance). They sample crystals, powder, and flakes to spot impurities and confirm homogeneity, which guards against clinical failures or adverse side effects. In research and development, the choice of physical form—whether powder, flakes, or pearls—affects solubility and mixing with other active or inactive compounds. Drug manufacturers blend sparfloxacin into tablets, capsules, and injectable solutions, guided by clinical protocols and patient safety guidelines. Storage in tightly sealed containers at room temperature, away from direct sunlight and moisture, further guards integrity.
Drug developers continue to explore sparfloxacin analogs and derivatives to combat rising bacterial resistance and reduce rare but significant side effects. Researchers focus their engineering on optimizing the molecular structure for increased selectivity, looking for less interaction with non-target cells and improved bioavailability. Production teams in manufacturing plants keep improving filtration and dust collection technologies for worker safety. In academic circles, studies examine environmental persistence and pathways for breakdown, aiming to create protocols for greener manufacturing and disposal processes. International trade teams monitor regulatory changes to ensure every export or import reaches its destination legally, ethically, and in a way that benefits public health, not just private profits.
